![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/research/ethris-inhaled-mrna-based-asthma-drug-ups-its-target-protein-without-toxicity-early-data
https://www.indianpharmapost.com/news/cipla-eu-to-invest-an-additional-3-million-in-ethris-15783
https://www.globenewswire.com//news-release/2023/12/18/2797515/0/en/Ethris-Initiates-First-in-Human-Dosing-in-Phase-1-Study-of-ETH47-for-the-Treatment-of-Virus-Induced-Asthma.html
https://www.globenewswire.com//news-release/2023/11/13/2778715/0/en/Ethris-and-Heqet-Therapeutics-Announce-Collaboration-to-Develop-RNA-based-Therapeutics-for-Heart-Attack-and-Heart-Failure.html
https://www.globenewswire.com//news-release/2023/11/01/2771277/0/en/Ethris-Joins-Alliance-for-mRNA-Medicines-as-a-Founding-Member.html
https://www.globenewswire.com//news-release/2023/09/25/2748854/0/en/DIOSynVax-and-Ethris-Publish-Preclinical-Proof-of-Concept-for-Their-Broadly-Protective-Vaccine-Technologies-in-Nature-Biomedical-Engineering.html
https://www.prnewswire.com/news-releases/cipla-eu-to-invest-eur-15-million-in-ethris-initiating-a-strategic-collaboration-301711138.html